EichorEICHOR
Study identifier: NCT03950232 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Condition: Ulcerative Colitis  ·  Sponsor: Pfizer

PhasePhase 3
Planned participants896
Who can joinAll sexes, 16 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blind treatment (either etrasimod 2 mg per day or placebo) during participation in one of the qualified Phase 3 or Phase 2 double-blind, placebo-controlled parent studies including but not limited to: (APD334-301 \[NCT03945188\] or APD334-302 \[NCT03996369\] or APD334-210 \[NCT04607837\]).

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (470)

Center for Digestive Health (Colonoscopy Location)Dothan, Alabama, United States
Digestive Health Specialists (IP Address)Dothan, Alabama, United States
Flowers Hospital (PFT Location)Dothan, Alabama, United States
Pulmonary Associates (Secondary PFT Location)Dothan, Alabama, United States
Gut P.C., dba Digestive Health Specialists of the Southeast (IP Address)Dothan, Alabama, United States
Inland Pulmonary Specialists [PFT Only]Lake Elsinore, California, United States
A V Pediatrics,Allergy and Family MedicineLancaster, California, United States
Advanced Endoscopy and Pain Center(Colonoscopy)Lancaster, California, United States
Antelope Valley Eye Care(Ophthalmologist)Lancaster, California, United States
Jatinder S.Pruthi,MD FACG CPILancaster, California, United States
Om Research LLCLancaster, California, United States
Renaissance Imaging Center(Chest X-Ray only)Lancaster, California, United States

+ 458 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →